title: Emotional regulatory function of receptor interacting protein 140 revealed in the ventromedial hypothalamus.
abstract: Receptor-interacting protein (RIP140) is a transcription co-regulator highly expressed in macrophages to regulate inflammatory and metabolic processes. However, its implication in neurological, cognitive and emotional conditions, and the cellular systems relevant to its biological activity within the central nervous system are currently less clear. A transgenic mouse line with macrophage-specific knockdown of RIP140 was generated (MΦRIPKD mice) and brain-region specific RIP140 knockdown efficiency evaluated. Mice were subjected to a battery of tests, designed to evaluate multiple behavioral domains at naïve or following site-specific RIP140 re-expression. Gene expression analysis assessed TNF-α, IL-1β, TGF-1β, IL1-RA and neuropeptide Y (NPY) expression, and in vitro studies examined the effects of macrophage's RIP140 on astrocytes' NPY production. We found that RIP140 expression was dramatically reduced in macrophages within the ventromedial hypothalamus (VMH) and the cingulate cortex of MΦRIPKD mice. These animals exhibited increased anxiety- and depressive-like behaviors. VMH-targeted RIP140 re-expression in MΦRIPKD mice reversed its depressive- but not its anxiety-like phenotype. Analysis of specific neurochemical changes revealed reduced astrocytic-NPY expression within the hypothalamus of MΦRIPKD mice, and in vitro analysis confirmed that conditioned medium of RIP140-silnenced macrophage culture could no longer stimulate NPY production from astrocytes. The current study revealed an emotional regulatory function of macrophage-derived RIP140 in the VMH, and secondary dysregulation of NPY within hypothalamic astrocyte population, which might be associated with the observed behavioral phenotype of MΦRIPKD mice. This study highlights RIP140 as a novel target for the development of potential therapeutic and intervention strategies for emotional regulation disorders.
authors.affiliation: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
authors.forename: S
authors.initials: S
authors.lastname: Flaisher-Grinberg
authors.affiliation: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Department of Neurosurgery, Chang-Gung Memorial Hospital and University, Tao-Yuan, Taiwan, ROC.
authors.forename: H C
authors.initials: HC
authors.lastname: Tsai
authors.affiliation: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
authors.forename: X
authors.initials: X
authors.lastname: Feng
authors.affiliation: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA. Electronic address: weixx009@umn.edu.
authors.forename: L N
authors.initials: LN
authors.lastname: Wei
mesh_terms: D000818:Animals; D001007:Anxiety / Q000378:metabolism*; D001253:Astrocytes / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D003863:Depression / Q000378:metabolism*; D004644:Emotions / Q000502:physiology; D055785:Gene Knockdown Techniques; D008264:Macrophages / Q000378:metabolism*; D008297:Male; D051379:Mice; D009478:Neuropeptide Y / Q000378:metabolism; D056971:Nuclear Receptor Co-Repressor 1 / Q000235:genetics / Q000378:metabolism*; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D014697:Ventromedial Hypothalamic Nucleus / Q000378:metabolism*
chemical_list: D016207:Cytokines; D009478:Neuropeptide Y; D056971:Nuclear Receptor Co-Repressor 1; D012333:RNA, Messenger
keywords: Anxiety; Depression; Immune system; NPY; RIP140; Ventromedial hypothalamus
references.citation: Cereb Cortex. 2012 Jun;22(6):1442-54
references.pmid: 21878486
references.citation: Curr Diabetes Rev. 2012 Nov;8(6):452-7
references.pmid: 22934550
references.citation: Neuropsychopharmacology. 2010 Sep;35(10):2083-100
references.pmid: 20571484
references.citation: Drugs. 2012 Sep 10;72(13):1725-38
references.pmid: 22901010
references.citation: Neuropeptides. 2012 Dec;46(6):299-308
references.pmid: 23116540
references.citation: Genes Brain Behav. 2008 Nov;7(8):915-23
references.pmid: 18700840
references.citation: Behav Brain Res. 2013 Jun 1;246:168-78
references.pmid: 23499706
references.citation: Brain Res Bull. 2012 Jan 4;87(1):10-20
references.pmid: 22024597
references.citation: Hum Psychopharmacol. 2009 Apr;24(3):165-75
references.pmid: 19212943
references.citation: J Neurosci. 2008 Dec 17;28(51):13815-27
references.pmid: 19091972
references.citation: Neuropeptides. 2004 Aug;38(4):213-24
references.pmid: 15337373
references.citation: Expert Opin Ther Targets. 2011 Nov;15(11):1317-31
references.pmid: 21995655
references.citation: J Immunol. 2013 Apr 1;190(7):3570-8
references.pmid: 23447691
references.citation: Neuroscience. 2009 Feb 6;158(3):1122-32
references.pmid: 18848864
references.citation: Mol Cell Endocrinol. 2003 May 30;203(1-2):91-103
references.pmid: 12782406
references.citation: Neuropsychopharmacology. 2004 Jan;29(1):1-14
references.pmid: 12942143
references.citation: Curr Top Behav Neurosci. 2013;14:101-34
references.pmid: 23018753
references.citation: Mol Cell Endocrinol. 2009 Mar 5;300(1-2):132-6
references.pmid: 18951950
references.citation: Cell Mol Immunol. 2012 May;9(3):195-6
references.pmid: 22504951
references.citation: Nat Protoc. 2006;1(3):1494-501
references.pmid: 17406440
references.citation: Int J Neuropsychopharmacol. 2013 Sep;16(8):1781-98
references.pmid: 23521775
references.citation: Addict Biol. 2003 Sep;8(3):295-303
references.pmid: 13129831
references.citation: Cereb Cortex. 2014 Jun;24(6):1518-28
references.pmid: 23349224
references.citation: Amino Acids. 2013 Jul;45(1):41-53
references.pmid: 22143431
references.citation: Mol Brain. 2011 Jan 19;4:6
references.pmid: 21247477
references.citation: J Neurol Sci. 2002 Oct 15;202(1-2):13-23
references.pmid: 12220687
references.citation: Behav Genet. 2006 May;36(3):439-53
references.pmid: 16502135
references.citation: Nat Immunol. 2012 Mar 04;13(4):379-86
references.pmid: 22388040
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:213-20
references.pmid: 23367508
references.citation: Mol Endocrinol. 2008 Jun;22(6):1403-15
references.pmid: 18372344
references.citation: Genes Brain Behav. 2012 Feb;11(1):69-78
references.pmid: 21906262
references.citation: J Am Acad Dermatol. 1987 Jul;17(1):25-32
references.pmid: 2956296
references.citation: J Neurosci Res. 2009 Aug 15;87(11):2591-600
references.pmid: 19326447
references.citation: Cell Metab. 2006 Jul;4(1):13-24
references.pmid: 16814729
references.citation: Cell Biol Toxicol. 2011 Feb;27(1):1-12
references.pmid: 20419501
references.citation: PLoS One. 2008 Jun 25;3(6):e2507
references.pmid: 18575609
references.citation: Nature. 2012 Oct 11;490(7419):165-7
references.pmid: 23060171
references.citation: Neurosci Behav Physiol. 2003 Mar;33(3):255-61
references.pmid: 12762592
references.citation: Exp Clin Endocrinol Diabetes. 2013 Jan;121(1):37-42
references.pmid: 22956256
references.citation: Adv Protein Chem Struct Biol. 2012;88:1-25
references.pmid: 22814704
references.citation: Neuropsychopharmacology. 2012 Jan;37(2):350-63
references.pmid: 21976046
references.citation: Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3152-4
references.pmid: 18269878
references.citation: Brain Behav Immun. 2013 Jan;27(1):22-32
references.pmid: 22985767
references.citation: Eur J Neurosci. 2008 Jul;28(1):173-80
references.pmid: 18616565
references.citation: Braz J Med Biol Res. 2010 Sep;43(9):869-73
references.pmid: 20694443
references.citation: Cell Signal. 2012 Jan;24(1):71-6
references.pmid: 21872658
references.citation: Genetika. 2010 Oct;46(10):1348-51
references.pmid: 21254553
references.citation: Neuron. 2008 Mar 27;57(6):809-18
references.pmid: 18367082
references.citation: Neurology. 2007 May 29;68(22 Suppl 3):S58-63; discussion S91-6
references.pmid: 17548571